The bacteriolytic action of MT-141, a new cephamycin antibiotic, on gram-negative bacteria. 1985

T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi

MT-141, a new cephamycin (7 alpha-methoxy-cephalosporin) antibiotic with a D-cysteine moiety in its 7 beta-side chain, has binding affinities to penicillin-binding proteins of Escherichia coli and an inhibitory action on their transpeptidase activity similar to those of other structurally related cephamycins. Yet this antibiotic was found to exert an exceedingly strong and rapid lytic action on sensitive Gram-negative bacteria such as E. coli, Klebsiella pneumoniae, Serratia marcescens and Salmonella enteritidis. Not only rapidly growing cells, but also slowly growing dense cells of the above bacteria could be lysed by this antibiotic at low concentrations. In the presence of 20% sucrose, low concentrations of MT-141 induced smooth-surfaced single and twin bulges of the putative growth zone of the cells and irregularly orientated rough-surfaced bulges. Probably the 7 beta-side chain structure of this antibiotic is involved in its rapid and strong bacteriolytic action.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010400 Penicillin G A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin GrĂ¼nenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010458 Peptidyl Transferases Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases. Peptidyl Transferase,Peptidyl Translocase,Peptidyl Translocases,Peptidyltransferase,Transpeptidase,Transpeptidases,Peptidyltransferases,Transferase, Peptidyl,Transferases, Peptidyl,Translocase, Peptidyl,Translocases, Peptidyl
D002267 Muramoylpentapeptide Carboxypeptidase Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN. Carboxypeptidase Transpeptidase,Carboxypeptidase, Muramoylpentapeptide,Transpeptidase, Carboxypeptidase
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria

Related Publications

T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
January 1985, Drugs under experimental and clinical research,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
May 1984, The Japanese journal of antibiotics,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
July 1984, The Japanese journal of antibiotics,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
December 1984, The Journal of antibiotics,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
January 1989, Research in microbiology,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
November 1994, Antimicrobial agents and chemotherapy,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
June 1984, The Japanese journal of antibiotics,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
June 1984, The Japanese journal of antibiotics,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
June 1984, The Japanese journal of antibiotics,
T Tsuruoka, and Y Yamada, and H Goi, and K Miyauchi, and A Miyata, and S Inouye, and F Ishino, and A Hirata, and M Matsuhashi
June 1984, The Japanese journal of antibiotics,
Copied contents to your clipboard!